Abstract:To explore novel topoisomerase inhibitors with high activity and druggability, 3-aryl isoquinoline alkaloids based on the corydamine modification and preliminary SARs of isoquinoline alkaloids in our previous works were re-designed. Currently, the design strategy is mainly revolved around the rigidity and flexibility of the molecular side chain and the molecular size. Consequently, not only the activity and druggability of the compound could be further improved, also the mechanism behind could been discovered. In vitro pharmacological studies, the outstanding nature with the excellent activity and the researchable depth of azepane-substituted compound 7 has been found through the vitro cytotoxicity test (IC50 = 1.93 μM in HuH7 cells and 2.10 μM in LM9 cells) and topoisomerase test. It was found that compound 7 had dual inhibitory effects on topoisomerase I and II, and its inhibitory activity on topoisomerase II is stronger than the positive drug etoposide. From the perspective of molecular docking, it had been verified that compound 7 could insert between DNA base pairs, which was consistent with the results of the DNA unwinding experiment. And the comet experiment confirmed 7 caused DNA damage. Meanwhile, compound 7 could inhibit cell proliferation, invasion and migration, and induce apoptosis by inhibiting PI3K/Akt/mTOR signaling pathway. Therefore, this study may lay a foundation for the discovery of 3-arylisoquinoline compounds with anti-liver cancer potential.

Discovery of a Novel Series of Quinolone and Naphthyridine Derivatives As Potential Topoisomerase I Inhibitors by Scaffold Modification.

Synthesis and Biological Evaluation of 6-Fluoro-3-phenyl-7-piperazinyl Quinolone Derivatives As Potential Topoisomerase I Inhibitors.

Discovery of a Series of Pyridopyrimidine Derivatives As Potential Topoisomerase I Inhibitors

Synthesis, Cytotoxicity and Structure-Activity Relationship of Indolizinoquinolinedione Derivatives As DNA Topoisomerase IB Catalytic Inhibitors

Synthesis and Biological Evaluation of 6-Substituted Indolizinoquinolinediones As Catalytic DNA Topoisomerase I Inhibitors.

Synthesis and biological evaluation of 5-aminoethyl benzophenanthridone derivatives as DNA topoisomerase IB inhibitors.

A Novel Dna Topoisomerase I Inhibitor with Different Mechanism from Camptothecin Induces G2/M Phase Cell Cycle Arrest to K562 Cells

Discovery of Indolo[3,2- c]isoquinoline Derivatives as Novel Top1/2 Dual Inhibitors with Orally Efficacious Antitumor Activity and Low Toxicity

A novel topoisomerase I inhibitor DIA-001 induces DNA damage mediated cell cycle arrest and apoptosis in cancer cell.

Novel Securinine Derivatives As Topoisomerase I Based Antitumor Agents.

Synthesis and biological evaluations of novel indenoisoquinolines as topoisomerase I inhibitors.

Design, synthesis and biological evaluation of 3-substituted indenoisoquinoline derivatives as topoisomerase I inhibitors

Development of Indenoisoquinoline Derivatives as Novel Topoisomerase 1 Inhibitors

Novel 4-(4-substituted Amidobenzyl)furan-2(5H)-one Derivatives As Topoisomerase I Inhibitors.

Design, Synthesis and Biological Evaluation of 3-Arylisoquinoline Derivatives As Topoisomerase I and II Dual Inhibitors for the Therapy of Liver Cancer.

The Discovery and Optimization of Novel Dual Inhibitors of Topoisomerase Ii and Histone Deacetylase

Design, synthesis and evaluation of 4-substituted anthra[2,1-c][1,2,5]thiadiazole-6,11-dione derivatives as novel non-camptothecin topoisomerase I inhibitors

Design, Synthesis and Antitumor Activity of 3-Substituted Quinolone Derivatives (I)

Design, synthesis and biological evaluation of novel 7-alkylamino substituted benzo[a]phenazin derivatives as dual topoisomerase I/II inhibitors.

Synthesis and Biological Activities of 11-and 12-Substituted Benzophenanthridinone Derivatives As DNA Topoisomerase IB and Tyrosyl-DNA Phosphodiesterase 1 Inhibitors

New Strategies in the Discovery of Novel Non-Camptothecin Topoisomerase I Inhibitors